Visual scale of MRI evaluation of the brain atrophy on early stage of Alzheimer disease
Abstract
One of the most important parts in biomarkers research is finding of atrophic changes in strategic for cognition brain structures. In the study one of the structural neurovisual bi-omarkers of neuronal damage were analised - MRI visual scale of atrophy. 94 patients with early signs of Alzheimer disease were examined. Using of visual scales show atrophy slight and mild of mediobasal temporal lobe in 64 patients (68%), interuncal distance was Increased in 27 patients (28%). Atrophic changes of the cortex of parietal lobe were not found in most of patients.
About the Authors
N. G. Neznanov
Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
N. I. Ananyeva
Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
N. M. Zalutskaya
Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
I. R. Stulov
Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
I. E. Galsman
Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
J. A. Beltceva
Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
References
1. Емелин А.Ю., Одинак М.М., Труфанов Г.Е. Возможности позитронной эмиссионной томографии в дифференциальной диагностике деменций // Вестник Российской Военно-медицинской академии. - 2010. - № 4 (32). - С. 46-51.
2. Захаров В.В. Распространенность и лечение когнитивных нарушений в неврологической клинике // Неврологический журнал. - 2006. - № 11. - С. 27-32.
3. Незнанов Н.Г., Залуцкая Н.М., Захарченко Д.В., Дроздова М.А., Осипова В.А. Ранняя диагностика болезни Альцгеймера с использованием теста памяти Векслера // Материалы Второй всероссийской конференции с международным участием «Когнитивные и другие нервнопсихические расстройства». - 2011. - С. 77-78.
4. Незнанов Н.Г., Залуцкая Н.М., Дубинина Е.Е., Захарченко Д.В., Щедрина Л.В., Ананьева Н.И., Ющин К.В., Кубарская Л.Г., Дагаев С.Г., Трилис Я.Г. Исследование параметров окислительного стресса при психических нарушениях в позднем возрасте (болезнь Альцгеймера, сосудистая деменция, депрессивное расстройство) // Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. - 2013. - № 4. - С. 31-38.
5. Одинак М.М., Емелин А.Ю., Декан В.С. Современные возможности нейровизуализации в диагностике деменций // Психиатрия. - 2009. - № 1(37). - С. 57-61.
6. Одинак М.М., Емелин А.Ю., Лобзин В.Ю. Церебральная перфузия и когнитивные нарушения у больных с сосудистой деменцией // Медицинский академический журнал. - 2011. - № 11(1). - С. 58-64.
7. Деменции: руководство для врачей / Яхно Н.Н., Захаров В.В., Локшина А.Б., - 3 изд. - М.: МЕДпресс-информ, 2011. - 272 с.
8. Albert M, Blacker D, Moss MB, Tanzi R, McArdle JJ Longitudinal change in cognitive performance among individuals with mild cognitive impairment // Neuropsychology. - 2007. - № 21. - С. 158-169.
9. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NCGamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimer’s disease. // Alzheimers Dementia. - 2011. - № 7. - С. 270-279.
10. Atiya M., Hyman B., Albert M. et al. Structural magnetic resonance imaging in established and prodromal Alzheimer’s disease: a review. // Alzheimer Disease and Associated Disorders. - 2003. - № 17(3). - С. 177-195.
11. Bateman R.J., Xiong C., Benzinger T.L., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M., Holtzman D.M., Santacruz A., Buckles V., Oliver A., Moulder K., Aisen P.S., Ghetti B, Klunk W.E., McDade E., Martins R.N., Masters C.L., Mayeux R., Ringman J.M., Rossor M.N., Schofield P.R., Sperling R.A., Salloway S., Morris J.C. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. // New England Journal of Medicine. - 2012. - № 9.
12. Blennow K., Hampel H., Weiner M. et al. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease // Nature Reviews Neurology. - 2010. - № 6 (3). - С. 131-144.
13. Jack C.R., Albert M.S., Knopman D.S. et al. Introduction to the recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimer’s disease // Nature Reviews Neurology. - 2011. - № 7 (3). - С. 257-262.
14. Jagust W. Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia // Alzheimers Dementia. - 2006. - № 2 (1). - С. 36-42.
15. Kantarci K., Jack C. Neuroimaging in Alzheimer’s disease: an evidenced-based review // Neuroimaging Clinics of North America. - 2003. - № 13(2). - С. 197-209.
16. McKhann G.M. et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimers Association workshop on diagnostic guidelines for Alzheimer’s disease // Alzheimer’s & Dementia. - 2011. - № 7.
17. Mintun M.A., Larossa G.N., Sheline Y.I. et al. PIB in a nondemented population: potential antecedent marker of Alzheimer disease // Neurology. - 2006. - № 67 (3). - С. 446-452.
18. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and preclinical Alzheimer disease // Annals of Neurology. - 1999. - № 45. - С. 358-368.
19. Sheline Y.I., Morris J.C., Snyder A.Z. et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42 // J neurosci. - 2010. - № 30(50). - С. 135-140.
20. Sperling R.A. et al. Toward defining the preclini-cal stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimer’s disease. // Alzheimer’s & Dementia. - 2011. - № 7.
21. Stern Y. Cognitive reserve // Neuropsychologia. - 2009. - № 47. - С. 2015-2028.
22. Suzanne M de la Monte Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer’s Disease // Current Alzheimer Research. - 2012. - № 9(1).
23. Tapiola T., Alafuzoff I., Herukka S.K. et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. // Archives of Neurology. - 2009. - № 66 (3). - С. 382-389.
24. Vemuri P., Wiste H.J., Weigand S.D. et al. Serial MRI and CSF biomarkers in normal aging, MCI, and AD // Neurology. - 2010. - № 75(2). - С. 143-151. Исследования
25. Wimo A., Winbald B., Aguero Torres H., von Strauss E. The magnitude of dementia occurrence in the world // Alzheimer Disease and Associated Disorders. - 2003. - № 17. - С. 63-67.
Review
For citations:
Neznanov N.G., Ananyeva N.I., Zalutskaya N.M., Stulov I.R., Galsman I.E., Beltceva J.A. Visual scale of MRI evaluation of the brain atrophy on early stage of Alzheimer disease. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2016;(4):61-66. (In Russ.)
Views:
725
Email this article 